91 related articles for article (PubMed ID: 3534712)
1. [Inhibition of cephalosporinase of enterobacteria by ceftriaxone].
Péchinot A; Duez JM; Nordmann P; Kazmierczak A; Labia R
Pathol Biol (Paris); 1986 May; 34(5):399-403. PubMed ID: 3534712
[TBL] [Abstract][Full Text] [Related]
2. [HPLC study of the inhibition of enterobacterial cephalosporinases by cefmenoxime].
Pechinot A; Duez JM; Bryskier A; Labia R; Kazmierczak A
Pathol Biol (Paris); 1984 May; 32(5):386-8. PubMed ID: 6330649
[TBL] [Abstract][Full Text] [Related]
3. [In-vitro activity of ceftriaxone on Gram-negative bacilli with various resistance phenotypes to cephalosporins. Comparison with cefotaxime, cefmenoxime, moxalactam, ceftazidime].
Rouhan D; Le Noc P; Le Noc D
Pathol Biol (Paris); 1986 May; 34(5):404-9. PubMed ID: 3534713
[TBL] [Abstract][Full Text] [Related]
4. On the kinetic interaction between ceftriaxone and some beta-lactamases.
Amicosante G; Maccarrone M; Franceschini N; Oliva B; Segatore B; Oratore A
Drugs Exp Clin Res; 1988; 14(1):25-30. PubMed ID: 3260552
[TBL] [Abstract][Full Text] [Related]
5. [In vitro bacteriostatic activity of cefmenoxime (SCE 1365), cefotaxime and moxalactam].
Husson MO; Bryskier A; Izard D; Leclerc H
Pathol Biol (Paris); 1983 May; 31(5):347-50. PubMed ID: 6312395
[TBL] [Abstract][Full Text] [Related]
6. Hydrolytic model for cefotaxime and ceftriaxone resistance in beta-lactamase-derepressed Enterobacter cloacae.
Livermore DM; Riddle SJ; Davy KW
J Infect Dis; 1986 Mar; 153(3):619-22. PubMed ID: 3485161
[No Abstract] [Full Text] [Related]
7. Beta-lactamase stability and antibacterial activity of cefmenoxime (SCE-1365), a novel cephalosporin.
Okonogi K; Kuno M; Kida M; Mitsuhashi S
Antimicrob Agents Chemother; 1981 Aug; 20(2):171-5. PubMed ID: 6269488
[TBL] [Abstract][Full Text] [Related]
8. [In vitro evaluation of moxalactam on enterobacteria producing beta-lactamases].
Kazmierczak A; Pechinot A; Duez JM; Kohli E; Tremeaux JC
Sem Hop; 1983 Jun; 59(26):1953-7. PubMed ID: 6310785
[TBL] [Abstract][Full Text] [Related]
9. [Inducible cephalosporinase: study of Enterobacter hafniae].
Grasso S; Meinardi G; de Carneri I
G Ital Chemioter; 1985; 32(1):207-10. PubMed ID: 3913617
[No Abstract] [Full Text] [Related]
10. Cephalosporinase interactions and antimicrobial activity of BMY-28142, ceftazidime and cefotaxime.
Hiraoka M; Masuyoshi S; Mitsuhashi S; Tomatsu K; Inoue M
J Antibiot (Tokyo); 1988 Jan; 41(1):86-93. PubMed ID: 3279015
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of inhibition of chromosomal beta-lactamases by third-generation cephalosporins.
Charnas RL; Then RL
Rev Infect Dis; 1988; 10(4):752-60. PubMed ID: 3142012
[TBL] [Abstract][Full Text] [Related]
12. [Isolation and properties of beta-lactamase of the cephalosporinase type from cells of Enterobacter aerogenes 6803].
Sazykin AIu; Krylov AS; Navashin SM
Antibiotiki; 1984 Nov; 29(11):810-4. PubMed ID: 6335380
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of turnover of cefotaxime by the Enterobacter cloacae P99 and GCl beta-lactamases: two free enzyme forms of the P99 beta-lactamase detected by a combination of pre- and post-steady state kinetics.
Kumar S; Adediran SA; Nukaga M; Pratt RF
Biochemistry; 2004 Mar; 43(9):2664-72. PubMed ID: 14992604
[TBL] [Abstract][Full Text] [Related]
14. Behaviour of cefmenoxime towards beta-lactamases.
Labia R; Morand A; Ben Yaghlane H; Bryskier A
Drugs Exp Clin Res; 1985; 11(6):373-8. PubMed ID: 3939122
[TBL] [Abstract][Full Text] [Related]
15. [Characteristics of the substrate specificity of the crude endogenous beta-lactamases of gram-negative bacteria].
Bibikova MV; Ivanitskaia LP; Nikishina VG; Kuznetsova SM
Antibiotiki; 1983 Aug; 28(8):566-73. PubMed ID: 6416154
[TBL] [Abstract][Full Text] [Related]
16. Ways to overcome cephalosporinase-mediated beta-lactam resistance in Enterobacter cloacae.
Then RL; Angehrn P
Chemioterapia; 1985 Feb; 4(1):83-9. PubMed ID: 3872727
[TBL] [Abstract][Full Text] [Related]
17. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
Susić E
Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
[TBL] [Abstract][Full Text] [Related]
18. Differences between clavulanic acid and sulbactam in induction and inhibition of cephalosporinases in enterobacteria.
Kazmierczak A; Cordin X; Duez JM; Siebor E; Pechinot A; Sirot J
J Int Med Res; 1990; 18 Suppl 4():67D-77D. PubMed ID: 2282971
[TBL] [Abstract][Full Text] [Related]
19. Cefmenoxime (SCE-1365), a new cephalosporin: in vitro activity, comparison with other antimicrobial agents, beta-lactamase stability, and disk diffusion testing with tentative interpretive criteria.
Fuchs PC; Jones RN; Thornsberry C; Barry AL; Gerlach EH; Sommers HM
Antimicrob Agents Chemother; 1981 Dec; 20(6):747-59. PubMed ID: 6275784
[TBL] [Abstract][Full Text] [Related]
20. Affinity of cefmenoxime for beta-lactamases: an analysis.
Labia R; Morand A; Verchere-Beaur C; Bryskier A
Am J Med; 1984 Dec; 77(6A):25-7. PubMed ID: 6097119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
